+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Diagnostics Market - Global Forecast 2026-2032- Product Image
In-Vitro Diagnostics Market - Global Forecast 2026-2032- Product Image
New

In-Vitro Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904897
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

For senior decision-makers in the in-vitro diagnostics market, proactive evaluation of emerging technology trends, regulatory shifts, and evolving care delivery models is essential for driving informed investment, integration, and procurement strategies that align with organizational and clinical objectives.

Market Snapshot: In-Vitro Diagnostics Market Size and Trajectory

The in-vitro diagnostics market grew from USD 109.99 billion in 2025 to USD 117.31 billion in 2026 and is expected to reach USD 175.14 billion by 2032, achieving a compound annual growth rate of 6.87%. This steady growth is underpinned by advanced diagnostic instruments, widespread laboratory automation, the rise of digital health platforms, and increased investment in healthcare infrastructure globally. Diverse clinical environments are adopting integrated diagnostic solutions and digital tools, accelerating laboratory efficiency and supporting healthcare system modernization.

Scope & Segmentation of the In-Vitro Diagnostics Market

This report offers organizations a detailed framework to anticipate and address market evolution within in-vitro diagnostics. In-depth segmentation supports precise competitive benchmarking and informs forward-looking strategies in product innovation, procurement, and partnership decisions.

  • Product Types: Instruments such as analyzers, high-throughput automation systems, next-generation sequencing platforms, as well as reagents and assay kits tailored for diverse diagnostic needs; includes diagnostic software and expanded service offerings like calibration, consulting, and maintenance for full workflow support.
  • Test Modalities: Clinical chemistry, hematology, immunoassays, microbiology, and molecular diagnostics; each influences the pace of adoption and workflow integration across laboratory and clinical operations.
  • Specimen Types: Blood, serum and plasma, saliva, tissue, and urine; every specimen type presents unique requirements for collection, handling, and result accuracy in diagnostic processes.
  • Clinical Applications: Autoimmune diseases, oncology, cardiovascular care, diabetes management, genetic screening, and infectious disease testing, impacting care pathways from early detection to chronic disease management.
  • End-User Segments: Diagnostic laboratories, hospital systems, academic medical centers, and decentralized point-of-care sites, each with targeted procurement needs and varying levels of workflow sophistication.
  • Regional Coverage: Americas, Europe, Middle East & Africa, Asia-Pacific; regions considered for local regulatory contexts, differing healthcare financing models, and infrastructure maturity.
  • Technologies Featured: Molecular diagnostic platforms, automation technologies, advanced digital diagnostics, and integrated software deployments that improve accuracy and operational scalability.

Key Takeaways for Senior Decision-Makers

  • Advances in molecular diagnostics and laboratory informatics reshape operational models and help facilitate timely clinical decisions.
  • Increased adoption of decentralized and point-of-care testing highlights the strategic need for robust quality systems and seamless technical interoperability across multiple testing environments.
  • Procurement leaders should prioritize supply chain resilience and take regional regulatory requirements and shifting trade dynamics into account when evaluating supplier and sourcing strategies.
  • Aligning technology investments with user-specific operational and clinical needs enables organizations to deploy optimal solutions that reflect evolving workflow and support demands.
  • There is heightened demand for integrated product and service portfolios, enabling laboratories and healthcare providers to align hardware, reagents, and software for greater efficiency and value delivery.
  • Variations in regulatory frameworks and healthcare infrastructure across geographic regions require market approaches adapted to local expectations and rates of diagnostic technology adoption.

Tariff Impact on Diagnostic Equipment and Reagents

Recent tariff changes add operational complexity for organizations dependent on importing analyzers and reagents, elevating costs and extending production timelines. To manage uncertainty, buyers may diversify suppliers, reassess lifecycle costs, and negotiate comprehensive service terms, ensuring supply continuity and compliance with evolving trade and regulatory landscapes.

Research Methodology & Data Sources

This analysis synthesizes insights from direct interviews with laboratory executives, procurement specialists, and service managers, complemented by rigorous secondary research of regulatory documents, technical papers, and company filings. Cross-validation and risk-based frameworks guide findings to ensure reliable and objective conclusions.

Why This Report Matters

  • Equips executives and procurement teams to benchmark operational status against market trends, reinforcing investment planning and organizational agility.
  • Delivers actionable segmentation insights to facilitate optimal portfolio alignment and precise targeting across clinical and operational domains.
  • Supports proactive adjustment to regulatory dynamics and supply chain changes, empowering informed decision-making within evolving competitive environments.

Conclusion

Effective participation in the in-vitro diagnostics sector requires adaptable, segment-focused strategies. Organizations that align with shifting technology, operational needs, and regulatory standards are positioned to achieve ongoing value in clinical and organizational outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. In-Vitro Diagnostics Market, by Offering
8.1. Instruments
8.1.1. Analyzers
8.1.2. Automation Systems
8.1.3. Sequencing Instrument
8.2. Reagents & Kits
8.3. Services
8.3.1. Installation & Validation Services
8.3.2. Training & Consulting Services
8.3.3. Maintenance & Support Services
8.4. Software & Informatics
8.4.1. Laboratory Information Systems
8.4.2. Data Analytics & Interpretation Software
9. In-Vitro Diagnostics Market, by Test Type
9.1. Clinical Chemistry
9.1.1. Blood Analysis
9.1.2. Electrolyte Panel
9.1.3. Liver Panel
9.1.4. Thyroid Function Panel
9.1.5. Urine Analysis
9.2. Hematology
9.3. Immunoassays
9.4. Microbiology
9.5. Molecular Diagnostics
10. In-Vitro Diagnostics Market, by Specimen
10.1. Blood, Serum & Plasma
10.2. Saliva
10.3. Tissue Samples
10.4. Urine
11. In-Vitro Diagnostics Market, by Application
11.1. Autoimmune Diseases
11.2. Cancer Detection
11.3. Cardiac Monitoring
11.4. Diabetes Management
11.5. Genetic Testing
11.6. Infectious Disease Testing
12. In-Vitro Diagnostics Market, by End User
12.1. Academic & Research Centers
12.2. Diagnostic Laboratories
12.3. Hospitals
12.4. Point-Of-Care Testing Centers
13. In-Vitro Diagnostics Market, by Patient Type
13.1. Adults
13.2. Pediatrics
14. In-Vitro Diagnostics Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. In-Vitro Diagnostics Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. In-Vitro Diagnostics Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States In-Vitro Diagnostics Market
18. China In-Vitro Diagnostics Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Agappe Diagnostics Ltd.
19.7. Agilent Technologies, Inc.
19.8. ARKRAY Inc.
19.9. Asahi Kasei Corporation
19.10. Becton, Dickinson and Company
19.11. Bio-Rad Laboratories, Inc.
19.12. bioMérieux SA
19.13. Danaher Corporation
19.14. DiaSorin S.p.A.
19.15. Edan Instruments, Inc.
19.16. F. Hoffmann-La Roche Ltd.
19.17. Grifols S.A.
19.18. HiMedia Laboratories Pvt. Ltd.
19.19. Hitachi High-Tech Corporation
19.20. Hologic, Inc.
19.21. Illumina, Inc.
19.22. J Mitra & Co. Pvt. Ltd.
19.23. KAINOS Laboratories, Inc.
19.24. Kyowa Medex Co., Ltd.
19.25. Meril Diagnostics Pvt. Ltd.
19.26. Nihon Kohden Corporation
19.27. PerkinElmer, Inc.
19.28. QIAGEN N.V.
19.29. QuidelOrtho Corporation
19.30. Revvity, Inc.
19.31. Seegene, Inc.
19.32. Sekisui Medical Co., Ltd.
19.33. Shanghai Kehua Bio-engineering Co., Ltd.
19.34. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
19.35. Siemens AG
19.36. Sino Biopharmaceutical Limited
19.37. Sysmex Corporation
19.38. Thermo Fisher Scientific, Inc.
19.39. Tosoh Corporation
19.40. Transasia Bio-Medicals Ltd.
19.41. Werfen, S.A.
19.42. Zhejiang Orient Gene Biotech Co.,Ltd.
List of Figures
FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOMATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOMATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOMATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SEQUENCING INSTRUMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SEQUENCING INSTRUMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SEQUENCING INSTRUMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTALLATION & VALIDATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTALLATION & VALIDATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTALLATION & VALIDATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS & INTERPRETATION SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS & INTERPRETATION SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS & INTERPRETATION SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BLOOD ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BLOOD ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BLOOD ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BLOOD, SERUM & PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BLOOD, SERUM & PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BLOOD, SERUM & PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TISSUE SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TISSUE SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CANCER DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CANCER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CANCER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 171. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 173. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 175. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 176. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 178. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 179. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 193. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 195. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 196. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 197. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 198. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 199. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 200. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 201. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 218. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 219. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 220. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 221. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 222. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 223. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 224. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 227. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 229. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 230. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 231. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 232. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 233. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 234. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 235. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 249. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 251. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 252. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 253. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 254. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 255. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 256. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 257. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 258. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 260. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 262. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 263. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 264. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 265. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 266. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 267. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 268. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 269. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 271. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 272. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 273. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 274. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 275. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 276. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 277. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 278. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 279. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 280. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 282. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 294. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 295. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 296. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 297. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 298. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
TABLE 299. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 300. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 301. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
TABLE 302. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 303. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 304. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this In-Vitro Diagnostics market report include:
  • Abbott Laboratories
  • Agappe Diagnostics Ltd.
  • Agilent Technologies, Inc.
  • ARKRAY Inc.
  • Asahi Kasei Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Edan Instruments, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Grifols S.A.
  • HiMedia Laboratories Pvt. Ltd.
  • Hitachi High-Tech Corporation
  • Hologic, Inc.
  • Illumina, Inc.
  • J Mitra & Co. Pvt. Ltd.
  • KAINOS Laboratories, Inc.
  • Kyowa Medex Co., Ltd.
  • Meril Diagnostics Pvt. Ltd.
  • Nihon Kohden Corporation
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Revvity, Inc.
  • Seegene, Inc.
  • Sekisui Medical Co., Ltd.
  • Shanghai Kehua Bio-engineering Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens AG
  • Sino Biopharmaceutical Limited
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Transasia Bio-Medicals Ltd.
  • Werfen, S.A.
  • Zhejiang Orient Gene Biotech Co.,Ltd.

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 117.31 Billion
Forecasted Market Value ( USD ) by 2032 $ 175.14 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned39

Related Topics

Related Reports

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions - Product Image

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions

  • Report
  • 188 Pages
  • Global
From
U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease), By Test Location, By End Use, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease), By Test Location, By End Use, And Segment Forecasts, 2025 - 2030

  • Report
  • 358 Pages
  • United States
From
In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035 - Product Image

In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035

  • Report
  • North America
From
Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (April 16-17, 2026) - Product Image

Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (April 16-17, 2026)

  • Training
  • 2 Days
  • Global
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030 - Product Image

In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030

  • Report
  • 740 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.